Structural Characterization of the Inhibitory DNA Motif for the Type A (D)-CpG-Induced Cytokine Secretion and NK-Cell Lytic Activity in Mouse Spleen Cells

DNA and Cell Biology

Volumn 22, Issue 10, 2003, Pages 621-631

  Lenert, Petar ^a   Rasmussen, Wendy ^a   Ashman, Robert F ^a   Ballas, Zuhair K ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; OLIGODEOXYNUCLEOTIDE; PYRIMIDINE; TOLL LIKE RECEPTOR 9;

ADJUVANT ARTHRITIS; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; CONCENTRATION RESPONSE; CPG ISLAND; CYTOKINE RELEASE; CYTOLYSIS; DNA STRUCTURE; FEMALE; IMMUNITY; IMMUNOSTIMULATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; B-LYMPHOCYTES; CPG ISLANDS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; OLIGODEOXYRIBONUCLEOTIDES; PROTEIN SUBUNITS; SPLEEN;

ANIMALIA;

EID: 0242288068     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454903770238094     Document Type: Article

References (44)

1. BALLAS, Z.K., KRIEG, A.M., WARREN, T., RASMUSSEN, W., DAVIS, H.L., WALDSCHMIDT, M., and WEINER, G.L. (2001). Divergent therapeutic and immunological effects of oligonucleotides with distinct CpG motifs. J. Immunol. 167, 4878-4886.
2. BALLAS, Z.K., RASMUSSEN, W.L., and KRIEG, A.M. (1996). Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 157, 1840-1845.
3. BAUER, S., KIRSCHNING, C.J., HACKER, H., REDECKE, V., HAUSMANN, S., AKIRA, S., WAGNER, H., and LIPFORD, G.B. (2001). Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. USA 98, 9237-9242.
4. CHASE, J.H., HOOKER, N.A., MILDENSTEIN, K.L., KRIEG, A.M., and COWDERY, J.S. (1997). Bacterial DNA-induced NK cell IFN-γ production is dependent on macrophage secretion of IL-12. Clin. Immunol. Immunopathol. 84, 185-193.
5. CHU, R.S., TARGONI, O.S., KRIEG, A.M., LEHMANN, P.V., and HARDING, C.V. (1997). CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186, 1623-1631.
6. COWDERY, J.S., CHACE, J.H., YI, A.K., and KRIEG, A.M. (1996). Bacterial DNA induces NK cells to produce IFN-γ in vivo and increases the toxicity of lipopolysaccharides. J. Immunol. 156, 4570-4575.
7. DENG, G.M., and TARKOWSKI, A. (2000). The features of arthritis induced by CpG motifs in bacterial DNA. Arthritis Rheum. 43, 356-364.
8. DENG, G.M., NILSSON, I.M., VERDRENGH, M., COLLINS, L.V., and TARKOWSKI, A. (1999). Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat. Med. 5, 702-705.
9. GURSEL, I., GURSEL, M., YAMADA, H., ISHII, K.J., TAKESHITA, F., and KLINMAN, D.M. (2003). Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation. J. Immunol. 171, 1393-1400.
10. GURSEL, M., VERTHELYI, D., GURSEL, I., ISHII, K.J., and KLINMAN, D.M. (2002). Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide. J. Leukoc. Biol. 71, 813-820.
11. HALPERN, M.D., and PISETSKY, D.S. (1995). In vitro inhibition of murine IFNγ production by phosphorothioate deoxyguanosine oligomers. Immunopharmacology 29, 47-52.
12. HALPERN, M.D., KURLANDER, R.J., and PISETSKY, D.S. (1996). Bacterial DNA induces murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-α. Cell. Immunol. 167, 72-78.
13. HARTMANN, G., WEERATNA, R.D., BALLAS, Z.K., PAYETTE, P., BLACKWELL, S., SUPARTO, I., RASMUSSEN, W.L., WALDSCHMIDT, M., SAJUTHI, D., PURCELL, R.H., et al. (2000). Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J. Immunol. 164, 1617-1624.
14. HEMMI, H., KAISHO, T., TAKEDA, K., and AKIRA, S. (2003). The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J. Immunol. 170, 3059-3064.
15. HEMMI, H., TAKEUCHI, O., KAWAI, T., KAISHO, T., SATO, S., SANJO, H., MATSUMOTO, M., HOSHINO, K., WAGNER, H., TAKEDA, K., et al. (2000). A toll-like receptor recognized bacterial DNA. Nature 408, 740-745.
16. KARLSEDER, J., BROCCOLI, D., DAI, Y., HARDY, S., and DE LANGE, T. (1999). p53 and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283, 1321-1325.
17. KIMURA, Y., SONEHARA, K., KURAMOTO, E., MAKINO, T., YAMAMOTO, S., YAMAMOTO, T., KATAOKA, T., and TOKUNAGA, T. (1994). Binding of oliguanylate to scavenger receptors is required for oligonucleotides to augment NK cell activity and induce IFN. J. Biochem. 116, 991-994.
18. KLINMAN, D.M., YI, A-K., BEAUCAGE, S.L., CONOVER, J., and KRIEG, A.M. (1996). CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ. Proc. Natl. Acad. Sci. USA 93, 2879-2883.
19. KRIEG, A.M., YI, A-K., MATSON, S., WALDSCHMIDT, T.J., BISHOP, G.A., TEASDALE, R., KORETZKY, G.A., and KLINMAN, D.M. (1995). CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546-549.
20. KRUG, A., ROTHENFUSSER, S., HORNUNG, V., JAHRSDORFER, B., BLACKWELL, S., BALLAS, Z., ENDRES, S., KRIEG, A.M., and HARTMANN, G. (2001). Identification of CpG oligonucleotide sequences with high induction of IFN-a/β in plasmocytoid dendritic cells. Eur. J. Immunol. 31, 2154-2163.
21. LEADBETTER, E.A., RIFKIN, A.R., HOHLBAUM, A.M., BEAUDETTE, B.C., SCHLOMCHIK, M.J., and MARSHAK-ROTHSTEIN, A. (2002). Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416, 603-607.
22. LENERT, P., GOEKEN, A., HANDWERGER, B.S., and ASHMAN, R.F. (2003a). Innate immune responses in lupus-prone Palmerston North mice: Differential responses to LPS and bacterial DNA/CpG oligonucleotides. J. Clin. Immunol. 23, 202-213.
23. LENERT, P., STUNZ, L., YI, A-K., KRIEG, A.M., and ASHMAN, R.F. (2001). CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-κB activation. Antisense Nucleic Acid Drug Dev. 11, 247-256.
24. LENERT, P., YI, A-K., KRIEG, A.M., STUNZ, L., and ASHMAN, R.F. (2003b). Inhibitory oligonucleotides block the induction of AP-1 transcription factor by stimulatory CpG oligonucleotides in B cells. Antisense Nucleic Acid Drug Dev. 13, 143-150.
25. MESSINA, J.P., GILKESON, G.S., and PISETSKY, D.S. (1991). Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J. Immunol. 147, 1759-1764.
26. PISETSKY, D.S., and REICH, C.F. (2000). Inhibition of murine macrophage IL-12 production by natural and synthetic DNA. Clin. Immunol. 96, 198-204.
27. RAZ, E., TIGHE, H., SATO, Y., CORR, M., DUDLER, J.A., ROMAN, M., SWAIN, S.L., SPIEGELBERG, H.L., and CARSON, D.A. (1996). Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl. Acad. Sci. USA 93, 5141-5145.
28. RONAGHY, A., PRAKKEN, B.J., TAKABAYASHI, K., FIRESTEIN, G.S., BOYLE, D., ZVAILFLER, N.J., ROORD, S.T.A., ALBANI, S., CARSON, D.A., and RAZ, E. (2002). Immunostimulatory DNA sequences influence the course of adjuvant arthritis. J. Immunol. 168, 51-56.
29. ROTHENFUSSER, S., HORNUNG, V., KRUG, A., TOWAROWSKI, A., KRIEG, A.M., ENDRES, S., and HARTMANN, G. (2001). Distinct CpG oligonucleotide sequences activate human αδ T cells via interferon-α/-β. Eur. J. Immunol. 31, 3525-3534.
30. SELLON, R.K., TONKONAGY, S., SCHULTZ, M., DIELEMAN, L.A., GRENTHER, W., BALISH, E., RENNICK, D.M., and SARTOR, R.B. (1998). Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10 deficient mice. Infect. Immunity 66, 5224-5231.
31. STACEY, K.J., SWEET, M.J., and HUME, D.A. (1996). Macrophages ingest and are activated by bacterial DNA. J. Immunol. 157, 2116-2122.
32. STACEY, K.J., YOUNG, G.R., CLARK, F., SESTER, D.P., ROBERTS, T.L., NAIK, S., SWEET, M.J., and HUME, D.A. (2003). The molecular basis for the lack of immunostimulatory activity of vertebrate DNA. J. Immunol. 170, 3614-3620.
33. STUNZ, L.L., LENERT, P., PECKHAM, D., YI, A-K., HAXHINASTO, S., CHANG, M., KRIEG, A.M., and ASHMAN, R.F. (2002). Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells. Eur. J. Immunol. 32, 1212-1222.
34. TAKESHITA, F., LEIFER, C.A., GURSEL, I., ISHII, K.J., TAKESHITA, S., GURSEL, M., and KLINMAN, D.M. (2001). Cutting edge: Role of toll-like receptor 9 in CpG DNA-induced activation of human cells. J. Immunol. 167, 3555-3558.
35. TOKUNAGA, T., YAMAMOTO, H., SHAMADA, S., ABE, H., FUKUDA, T., FUJISAWA, Y., FARUTANI, Y., YANO, O., KATAOKA, T., and SUDO, T. (1984). Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J. Natl. Cancer Inst. 72, 955-962.
36. TRAGANOS, F., DARZYNKIEWICZ, Z., SHARPLESS, T., and MELAMED, M.R. (1977). Simultaneous staining of ribonucleic acid and deoxyribonucleic acid in unfixed cells using acridine orange in a flow cytometric system. J. Histochem. Cytochem. 25, 46-56.
37. VERTHELYI, D., ISHII, K.J., GURSEL, M., TAKESHITA, F., and KLINMAN, D.M. (2001). Human peripheral blood cells differentially recognize and respond to two distinct CpG motifs. J. Immunol. 166, 2372-2377.
38. WOLD, M.S. (1997). Replication protein A: A heterotrimeric, single-stranded DNA-binding protein required for eukaryotic DNA metabolism. Annu. Rev. Biochem. 66, 61-92.
39. YAMADA, H., GURSEL, I., TAKESHITA, F., CONOVER, J., ISHII, K.J., GURSEL, M., TAKESHITA, S., and KLINMAN, D.M. (2002). Effect of suppressive DNA on-CpG-induced immune activation. J. Immunol. 169, 5590-5594.
40. YAMAMOTO, S., YAMAMOTO, T., KATAOKA, T., KURAMOTO, E., YANO, O., and TOKUNAGA, T. (1992). Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J. Immunol. 148, 4072-4076.
41. YI, A.-K., CHANG, M., PECKHAM, D.W., KRIEG, A.M., and ASHMAN, R.F. (1998). CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J. Immunol. 160, 5898-5906.
42. YI, A.-K., and KRIEG, A.M. (1998). Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA. J. Immunol. 161, 4493-4497.
43. ZEUNER, R.A., ISHII, K.J., LIZAK, M.J., GURSEL, I., YAMADA, H., KLINMAN, D.M., and VERTHELYI, D. (2002). Reduction of CpG-induced arthritis by suppressive oligodeoxynucleotides. Arthritis Rheum. 46, 2219-2224.
44. ZHU, F.G., REICH, C.F., and PISETSKY, D.S. (2002). Inhibition of murine dendritic cell activation by synthetic phosphorothioate oligodeoxynucleotides. J. Leukoc. Biol. 72, 1154-1163.